ITRM Iterum Therapeutics Plc

Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally.

$1.36
As of 03/04/2021     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Micro cap
Health Care
Biotechnology
Ireland

05/25/2018
121,149,910
48,883,527
$193,839,856
0.00%
SEC Edgar Online
10-Q
10-K
45885H206


Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
0.00
0.94
0.00
115.31%
0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy